首页> 外文OA文献 >OL-006 Impact of mutation in HCV ISDR on the efficacy of the combined pegylated interferon/ribavirin therapy in Chinese patients with chronic hepatitis C virus genotype 1b infection

【2h】

OL-006 Impact of mutation in HCV ISDR on the efficacy of the combined pegylated interferon/ribavirin therapy in Chinese patients with chronic hepatitis C virus genotype 1b infection

机译：OL-006 HCV ISDR突变对聚乙二醇干扰素/利巴韦林联合治疗对中国慢性丙型肝炎病毒基因1b型患者疗效的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Li J.T.; Wei J.F.; Zhou Y.P.; Li W.; Zeng Y.L.; Wang J.J.; Zhou B.; Liu S.W.; Wu Y.S.; Hou J.L.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. OL-006 Impact of mutation in HCV ISDR on the efficacy of the combined pegylated interferon/ribavirin therapy in Chinese patients with chronic hepatitis C virus genotype 1b infection [J] . J.T.Li, J.F.Wei, Y.P.Zhou, International journal of infectious diseases : . 2011,第Supplementa1期

机译：OL-006 HCV ISDR突变对聚乙二醇干扰素/利巴韦林联合治疗对中国慢性丙型肝炎病毒基因1b型患者疗效的影响
2. Mutations in ISDR of NS5A gene influence interferon efficacy in Chinese patients with chronic hepatitis C virus genotype 1b infection. [J] . Shen C, Hu T, Shen L, Journal of gastroenterology and hepatology . 2007,第11期

机译：NS5A基因的ISDR突变影响中国慢性C型肝炎病毒1b型患者的干扰素疗效。
3. Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C [J] . YanoYoshihiko, SeoYasushi, MikiAkira, International journal of molecular medicine . 2012,第5期

机译：非结构性5A突变和对聚乙二醇化干扰素-α-2b联合利巴韦林治疗的快速病毒反应与基因型1b慢性丙型肝炎患者的治疗功效相关
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. Improvement of glucose and lipid metabolism with pegylated interferon-α plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus [O] . Shao Qing, Dong Ji, Bing Li, 2015

机译：聚乙二醇干扰素-α联合利巴韦林改善中国慢性感染1b型丙型肝炎病毒患者的糖脂代谢
7. Serum Lipoprotein Profiles and Response to Pegylated Interferon Plus Ribavirin Combination Therapy in Patients With Chronic HCV Genotype 1b Infection [O] . Yoshio Aizawa, Noritomo Shimada, Hiroshi Abe, 2013

机译：血清脂蛋白谱和对慢性HCV基因型1B感染患者的PEGAMED干扰素加利巴韦林组合治疗的反应

OL-006 Impact of mutation in HCV ISDR on the efficacy of the combined pegylated interferon/ribavirin therapy in Chinese patients with chronic hepatitis C virus genotype 1b infection

著录项

引文网络

相似文献

相关主题

期刊订阅